[1]
|
赵辨. 中国临床皮肤病学[M]. 第2版. 南京: 江苏凤凰科学技术出版社, 2017: 775.
|
[2]
|
Bazargan, A.S., Tabavar, A., Roohaninasab, M., Ali, Z.N., Tavana, Z., Montazeri, S.S.M., et al. (2023) Evaluation of the Effect of Botulinum Toxin Injection in Aggravating or Improving Seborrheic Dermatitis Symptoms: A Prospective, Single-Arm Clinical Trial. Skin Research and Technology, 29, e13478. https://doi.org/10.1111/srt.13478
|
[3]
|
Suchonwanit, P., Triyangkulsri, K., Ploydaeng, M. and Leerunyakul, K. (2019) Assessing Biophysical and Physiological Profiles of Scalp Seborrheic Dermatitis in the Thai Population. BioMed Research International, 2019, 1-6. https://doi.org/10.1155/2019/5128376
|
[4]
|
张凡, 李沅鸿, 李姝润, 任伟, 陈燕超. 脂溢性皮炎临床诊治的研究进展[J]. 中国医疗美容, 2022, 12(10): 83-90.
|
[5]
|
Nenoff, P., Haustein, U.-F. and Fiedler, A. (1995) The Antifungal Activity of a Coal Tar Gel on Malassezia Furfur in Vitro. Dermatology, 191, 311-314. https://doi.org/10.1159/000246582
|
[6]
|
Piérard-Franchimont, C., Piérard, G.E., Vroome, V., Lin, G.C. and Appa, Y. (2000) Comparative Anti-Dandruff Efficacy between a Tar and a Non-Tar Shampoo. Dermatology, 200, 181-184. https://doi.org/10.1159/000018362
|
[7]
|
Melhorn, S. (2017) Salicylsäure-Öle zur Anwendung auf der Kopfhaut. Der Hautarzt, 68, 248-249. https://doi.org/10.1007/s00105-017-3949-9
|
[8]
|
胡杏林, 程茜, 袁江, 等. 水杨酸去屑护发露治疗头皮脂溢性皮炎临床疗效研究[J]. 疾病监测与控制, 2021, 15(4): 258-261.
|
[9]
|
Piquero-Casals, J., Morgado-Carrasco, D., Granger, C., Trullàs, C., Jesús-Silva, A. and Krutmann, J. (2021) Urea in Dermatology: A Review of Its Emollient, Moisturizing, Keratolytic, Skin Barrier Enhancing and Antimicrobial Properties. Dermatology and Therapy, 11, 1905-1915. https://doi.org/10.1007/s13555-021-00611-y
|
[10]
|
Celleno, L., D’amore, A. and Cheong, W.K. (2022) The Use of Urea Cream for Hand Eczema and Urea Foam for Seborrheic Dermatitis and Psoriasiform Dermatoses of the Scalp. Clinical, Cosmetic and Investigational Dermatology, 15, 2445-2454. https://doi.org/10.2147/ccid.s377718
|
[11]
|
周淑华, 王玉. 丙二醇治疗头皮脂溢性皮炎182例疗效观察[J]. 滨州医学院学报, 1997, 20(2): 22-23.
|
[12]
|
Emtestam, L., Svensson, Å. and Rensfeldt, K. (2011) Treatment of Seborrhoeic Dermatitis of the Scalp with a Topical Solution of Urea, Lactic Acid, and Propylene Glycol (K301): Results of Two Double-Blind, Randomised, Placebo-Controlled Studies. Mycoses, 55, 393-403. https://doi.org/10.1111/j.1439-0507.2011.02126.x
|
[13]
|
Faergemann, J. (1988) Propylene Glycol in the Treatment of Seborrheic Dermatitis of the Scalp: A Double-Blind Study. Cutis, 42, 69-71.
|
[14]
|
Goularte-Silva, V. and Paulino, L.C. (2021) Ketoconazole Beyond Antifungal Activity: Bioinformatics-Based Hypothesis on Lipid Metabolism in Dandruff and Seborrheic Dermatitis. Experimental Dermatology, 31, 821-822. https://doi.org/10.1111/exd.14505
|
[15]
|
Draelos, Z.D., Feldman, S.R., Butners, V., et al. (2013) Long-Term Safety of Ketoconazole Foam, 2% in the Treatment of Seborrheic Dermatitis: Results of a Phase IV, Open-Label Study. Journal of Drugs in Dermatology, 12, e1-e6.
|
[16]
|
Peter, R.U. and Richarz-Barthauer, U. (1995) Successful Treatment and Prophylaxis of Scalp Seborrhoeic Dermatitis and Dandruff with 2% Ketoconazole Shampoo: Results of a Multicentre, Double-Blind, Placebo-Controlled Trial. British Journal of Dermatology, 132, 441-445. https://doi.org/10.1111/j.1365-2133.1995.tb08680.x
|
[17]
|
Turcu, G., Artenie, C., Nowicka, D., Arenbergerová, M., Lazaridou, E., Khobzei, K., et al. (2023) Selenium Disulfide-Based Shampoo Applied for 4 Weeks Significantly Improves Dandruff and Seborrheic Dermatitis. European Journal of Dermatology, 33, 19-23. https://doi.org/10.1684/ejd.2023.4402
|
[18]
|
Massiot, P., Reygagne, P., Chagnoleau, C., Kanoun-Copy, L., Pouradier, F., Loussouarn, G., et al. (2023) Maintenance Effect of a Once-Weekly Regimen of a Selenium Disulfide-Based Shampoo in Moderate-to-Severe Scalp Seborrheic Dermatitis after Initial Treatment with Topical Corticosteroid/Salicylic Acid. European Journal of Dermatology, 33, 13-18. https://doi.org/10.1684/ejd.2023.4401
|
[19]
|
Ermolayeva, E. and Sanders, D. (1995) Mechanism of Pyrithione-Induced Membrane Depolarization in Neurospora Crassa. Applied and Environmental Microbiology, 61, 3385-3390. https://doi.org/10.1128/aem.61.9.3385-3390.1995
|
[20]
|
Chandler, C.J. and Segel, I.H. (1978) Mechanism of the Antimicrobial Action of Pyrithione: Effects on Membrane Transport, ATP Levels, and Protein Synthesis. Antimicrobial Agents and Chemotherapy, 14, 60-68. https://doi.org/10.1128/aac.14.1.60
|
[21]
|
Reeder, N.L., Xu, J., Youngquist, R.S., Schwartz, J.R., Rust, R.C. and Saunders, C.W. (2011) The Antifungal Mechanism of Action of Zinc Pyrithione. British Journal of Dermatology, 165, 9-12. https://doi.org/10.1111/j.1365-2133.2011.10571.x
|
[22]
|
Reeder, N.L., Kaplan, J., Xu, J., Youngquist, R.S., Wallace, J., Hu, P., et al. (2011) Zinc Pyrithione Inhibits Yeast Growth through Copper Influx and Inactivation of Iron-Sulfur Proteins. Antimicrobial Agents and Chemotherapy, 55, 5753-5760. https://doi.org/10.1128/aac.00724-11
|
[23]
|
Schwartz, J.R. (2005) Product Pharmacology and Medical Actives in Achieving Therapeutic Benefits. Journal of Investigative Dermatology Symposium Proceedings, 10, 198-200. https://doi.org/10.1111/j.1087-0024.2005.10105.x
|
[24]
|
Park, M., Cho, Y., Lee, Y.W. and Jung, W.H. (2018) Understanding the Mechanism of Action of the Anti-Dandruff Agent Zinc Pyrithione against Malassezia Restricta. Scientific Reports, 8, Article No. 12086. https://doi.org/10.1038/s41598-018-30588-2
|
[25]
|
Schwartz, J.R., Cardin, C.W., DeAngelis, Y.M. and Dawson, T.L. (2010) Dandruff and Seborrheic Dermatitis. In: Series in Cosmetic and Laser Therapy, Informa Healthcare, 230-241. https://doi.org/10.3109/9781841847641.029
|
[26]
|
Mangion, S.E., Mackenzie, L., Roberts, M.S. and Holmes, A.M. (2023) Seborrheic Dermatitis: Topical Therapeutics and Formulation Design. European Journal of Pharmaceutics and Biopharmaceutics, 185, 148-164. https://doi.org/10.1016/j.ejpb.2023.01.023
|
[27]
|
Shin, H., Kwon, O.S., Won, C.H., Kim, B.J., Lee, Y.W., Choe, Y.B., et al. (2009) Clinical Efficacies of Topical Agents for the Treatment of Seborrheic Dermatitis of the Scalp: A Comparative Study. The Journal of Dermatology, 36, 131-137. https://doi.org/10.1111/j.1346-8138.2009.00607.x
|
[28]
|
Ortonne, J.-P., Nikkels, A.F., Reich, K., Ponce Olivera, R.M., Lee, J.H., Kerrouche, N., et al. (2011) Efficacious and Safe Management of Moderate to Severe Scalp Seborrhoeic Dermatitis Using Clobetasol Propionate Shampoo 0·05% Combined with Ketoconazole Shampoo 2%: A Randomized, Controlled Study. British Journal of Dermatology, 165, 171-176. https://doi.org/10.1111/j.1365-2133.2011.10269.x
|
[29]
|
Rigopoulos, D., Ioannides, D., Kalogeromitros, D., Gregoriou, S. and Katsambas, A. (2004) Pimecrolimus Cream 1% Vs. Betamethasone 17-Valerate 0.1% Cream in the Treatment of Seborrhoeic Dermatitis. a Randomized Open-Label Clinical Trial. British Journal of Dermatology, 151, 1071-1075. https://doi.org/10.1111/j.1365-2133.2004.06208.x
|
[30]
|
Ishida, T., Mizushina, Y., Yagi, S., Irino, Y., Nishiumi, S., Miki, I., et al. (2012) Inhibitory Effects of Glycyrrhetinic Acid on DNA Polymerase and Inflammatory Activities. Evidence-Based Complementary and Alternative Medicine, 2012, 1-9. https://doi.org/10.1155/2012/650514
|
[31]
|
Wang, C., Kao, T., Lo, W. and Yen, G. (2011) Glycyrrhizic Acid and 18β-Glycyrrhetinic Acid Modulate Lipopolysaccharide-Induced Inflammatory Response by Suppression of NF-κB through PI3K P110δ and P110γ Inhibitions. Journal of Agricultural and Food Chemistry, 59, 7726-7733. https://doi.org/10.1021/jf2013265
|
[32]
|
Wang, H., Wang, C., Hsieh, S., Hung, Y. and Chen, H. (2021) Evaluation of a New-Formula Shampoo Containing 6% Glycyrrhetinic Acid Complex for Scalp Seborrheic Dermatitis: A Pilot Study. Journal of Cosmetic Dermatology, 21, 3423-3430. https://doi.org/10.1111/jocd.14623
|
[33]
|
Adalsteinsson, J.A., Kaushik, S., Muzumdar, S., Guttman-Yassky, E. and Ungar, J. (2020) An Update on the Microbiology, Immunology and Genetics of Seborrheic Dermatitis. Experimental Dermatology, 29, 481-489. https://doi.org/10.1111/exd.14091
|
[34]
|
Gooderham, M., Kircik, L., Zirwas, M., Lee, M., Kempers, S., Draelos, Z., et al. (2023) The Safety and Efficacy of Roflumilast Cream 0.15% and 0.05% in Patients with Atopic Dermatitis: Randomized, Double-Blind, Phase 2 Proof of Concept Study. Journal of Drugs in Dermatology, 22, 139-147. https://doi.org/10.36849/jdd.7295
|
[35]
|
Kircik, L.H., Alonso-Llamazares, J., Bhatia, N., Bukhalo, M., Devani, A.R., Draelos, Z.D., et al. (2023) Once-Daily Roflumilast Foam 0.3% for Scalp and Body Psoriasis: A Randomized, Double-Blind, Vehicle-Controlled Phase IIB Study. British Journal of Dermatology, 189, 392-399. https://doi.org/10.1093/bjd/ljad182
|
[36]
|
Thurston, A.W., Osborne, D.W., Snyder, S., Higham, R.C., Burnett, P. and Berk, D.R. (2022) Pharmacokinetics of Roflumilast Cream in Chronic Plaque Psoriasis: Data from Phase I to Phase III Studies. American Journal of Clinical Dermatology, 24, 315-324. https://doi.org/10.1007/s40257-022-00741-9
|
[37]
|
Lebwohl, M.G., Papp, K.A., Stein Gold, L., Gooderham, M.J., Kircik, L.H., Draelos, Z.D., et al. (2020) Trial of Roflumilast Cream for Chronic Plaque Psoriasis. New England Journal of Medicine, 383, 229-239. https://doi.org/10.1056/nejmoa2000073
|
[38]
|
Blauvelt, A., Draelos, Z.D., Stein Gold, L., Alonso-Llamazares, J., Bhatia, N., DuBois, J., et al. (2024) Roflumilast Foam 0.3% for Adolescent and Adult Patients with Seborrheic Dermatitis: A Randomized, Double-Blinded, Vehicle-Controlled, Phase 3 Trial. Journal of the American Academy of Dermatology, 90, 986-993. https://doi.org/10.1016/j.jaad.2023.12.065
|